Also trades as: 4582.T (JPX) · $vol 0M
SYMQY OTC
SymBio Pharmaceuticals Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -12.4%
1Y: -41.5%
3Y: -92.0%
5Y: -77.2%
$0.56
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4.8B
-40.4% ▼
Capital Expenditures
$525
+100.0% ▲
5Y CAGR: -91.9%
Free Cash Flow
-$4.8B
-38.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$51K
+99.7% ▲
Net Change in Cash
-$1.1B
+58.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.0B | $2.1B | -$1.2B | -$3.8B | -$5.0B |
| Depreciation & Amort. | $94M | $98M | $96M | $0 | $0 |
| Stock-Based Comp. | $124M | $105M | $82M | $93M | $0 |
| Change in Working Capital | -$1.1B | -$60M | $1.1B | $263M | -$196M |
| Other Non-Cash Items | $14M | $155M | -$246M | $34M | $407M |
| Operating Cash Flow | $140M | $1.6B | -$195M | -$3.4B | -$4.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$64M | -$48M | -$204M | -$20M | -$86M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$16K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$7M | $431K | -$173M | $16M | $7M |
| Investing Cash Flow | -$71M | -$47M | -$377M | -$4M | -$80M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $716M |
| Stock Repurchased | -$73M | -$48M | $0 | -$20M | -$51K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1K | $14M | -$1K | $0 | $157 |
| Financing Cash Flow | -$72M | $628M | $680M | $708M | $3.8B |
| Net Change in Cash | $11M | $2.4B | $234M | -$2.6B | -$1.1B |
| Cash End of Period | $3.9B | $6.3B | $6.5B | $4.0B | $2.9B |
| Free Cash Flow | $76M | $1.6B | -$427M | -$3.5B | -$4.8B |